(Q48315153)

10 February 2018

http://europepmc.org/abstract/MED/28120247

title

Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro (English)

1 reference

10 February 2018

http://europepmc.org/abstract/MED/28120247

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

April Camilla Roslani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Swee Hung Cheah

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

24 January 2017

1 reference

10 February 2018

http://europepmc.org/abstract/MED/28120247

published in

In Vitro Cellular & Developmental Biology - Animal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

435-447

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Tumor suppressor gene p16/INK4A/CDKN2A-dependent regulation into and out of the cell cycle in a spontaneous canine model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Epigenetic and genetic features of 24 colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Cellular heterogeneity: do differences make a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Culture of low passage colorectal cancer cells and demonstration of variation in selected tumour marker expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

The complexity of prostate cancer: genomic alterations and heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

The causes and consequences of genetic heterogeneity in cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Transcriptional regulation of human DNA repair genes following genotoxic stress: trigger mechanisms, inducible responses and genotoxic adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Cancer heterogeneity: implications for targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Nuclear transcription factor-kappaB as a target for cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Circulating tumor cells: the substrate of personalized medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

STATing the importance of immune modulation by platinum chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Drug resistance in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Capecitabine: a novel agent for the treatment of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Synergistic drug combinations tend to improve therapeutically relevant selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Technologies for deriving primary tumor cells for use in personalized cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

NF-kappaB as a therapeutic target in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

p53 regulation of DNA excision repair pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-016-0126-X

21 January 2018

1 reference

12 December 2020

Analysis of Drug Interactions

1 reference

12 December 2020

Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle

1 reference

12 December 2020

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapy.

1 reference

12 December 2020

Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide

1 reference

12 December 2020

The challenge of culturing human colorectal tumor cells: establishment of a cell culture model by the comparison of different methodological approaches

1 reference

12 December 2020

CTC enumeration and characterization: moving toward personalized medicine

1 reference

12 December 2020

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

12 December 2020

Excision repair cross complementing-group 1: gene expression and platinum resistance.

1 reference

12 December 2020

5-Fluorouracil-induced apoptosis in colorectal cancer cells is caspase-9-dependent and mediated by activation of protein kinase C-δ

1 reference

12 December 2020

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

1 reference

12 December 2020

Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells

1 reference

12 December 2020

10.1007/S11626-016-0126-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28120247%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference